Last reviewed · How we verify

NCT04340973

Comparing Transcranial Direct Current Stimulation Montages in Stroke

Status unknown NA Last updated 19 May 2020
What this trial tests

NA trial testing Transcranial Direct Current Stimulation in Acute Stroke in 40 participants. Status unknown.

Timeline
7 May 2020
Primary endpoint
1 July 2020
1 July 2020

Quick facts

Lead sponsorUniversity of Liege
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment40
Start date7 May 2020
Primary completion1 July 2020
Estimated completion1 July 2020
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University of Liege

Who can join

Adults 18 to 80, any sex, with Acute Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

40 acute subjects will be split into 5 groups. Each group will receive one of the following tDCS montages : anodal, bilateral, cathodal, extracephalic or placebo. Subjects will receive, in addition to conventional rehabilitation, 2mA for 20 mins of their attributed tDCS, 5 times a week. Evaluations will take place before the first stimulation period (48h post stroke), after 1, 2, 3 and 4 weeks. Evaluations consist of the Wolf Motor Function Test, the Fugl Meyer, and the Semmes Weinstein Monofilament Test

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcranial Direct Current Stimulation

Trials testing the same drug.

Other recruiting trials for Acute Stroke

Currently open trials in the same condition.

Other University of Liege trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04340973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing